About the Study
According to the latest Deloitte report*, currently the vast majority of chronic pain sufferers are not being helped by any treatment, whether that is medication, physical therapy, or psychological treatment, or a combination of all three.
This represents hundreds of billions of dollars of expense, but more importantly represents some 1.5 billion people who are not able to fully engage with their families, workplaces, and communities, and are living each day in pain.
This is a Phase 3 clinical trial of SDR Therapy for non-malignant chronic pain without adequate explanatory pathology, which represents some 95% of all chronic pain types.
SDR Therapy takes advantage of the well-accepted view that most chronic pain is mediated by the brain, rather than by an old injury, even though the pain itself is very real and in most cases will feel like it’s coming from the exact same location.
Previous small studies have shown SDR Therapy to be highly effective for this kind of chronic pain, and it is important to test whether this strategy remains effective when provided remotely, to many more people.
*Painaustralia.The Cost of Pain in Australia.2019;(March):121